Mucogingival
Surgery

The clinical literature is unambiguous: keratinised tissue width and mucosal thickness are independent predictors of peri-implant health over time. Implants placed into thin, non-keratinised mucosa carry a higher long-term risk of recession, bone loss, and peri-implantitis — regardless of how well the surgery is executed.

This is the Invisible Line at the tissue level. The quality of the peri-implant seal is determined by decisions that are invisible in the final result — but always felt over years of follow-up.

"Soft tissue management is not an aesthetic add-on. It is the biological engineering that determines whether a rehabilitation is still stable at year ten."

Mucogingival surgery is most predictable when planned proactively — before or simultaneously with implant placement — rather than as a reactive correction to recession that has already established itself.

When to consider mucogingival surgery:

Recession around natural teeth — especially in the aesthetic zone — where root exposure is progressive, symptomatic, or likely to worsen with orthodontic movement or ageing.

Peri-implant mucosal deficiency — thin tissue biotype, absence of keratinised mucosa, or inadequate tissue volume around existing or planned implants.

Pre-implant augmentation — where tissue architecture is insufficient to support a predictable implant outcome without prior or simultaneous soft tissue management.

Combined with GBR — simultaneous connective tissue grafting and guided bone regeneration in a single surgical session, addressing both hard and soft tissue deficiencies together.